Consists of Citric Acid, Sodium Bicarbonate, Sodium Citrate, Tartaric Acid
|
||
Citro-Soda Pregnancy |
||
Consists of Citric Acid, Sodium Bicarbonate, Sodium Citrate, Tartaric Acid
Due to the undesirable side effects of sodium loading--edema and weight gain--the use of alternative antacids has been advocated by some experts. In one unblinded, controlled study of the maternal and fetal effects of 150 mEq of Sodium Bicarbonate (Citro-Soda), use of the drug was associated with significantly elevated maternal arterial pH, pC02, and base excess and significantly elevated umbilical arterial pH, p02, and base excess at delivery. There were apparent adverse effects of the infusion on the mothers, and no mention of adverse effects on the fetuses or newborns.
Sodium Bicarbonate (Citro-Soda) has been assigned to pregnancy category C by the FDA. There are no animal or human reproductive data. Some experts consider the use of Sodium Bicarbonate (Citro-Soda) as an antacid during human pregnancy to be relatively contraindicated because of the availability of preferable therapeutic agents. Sodium Bicarbonate (Citro-Soda) should only be given during pregnancy when benefit outweighs risk.
See references
There are no data on the excretion of Sodium Bicarbonate (Citro-Soda) into human milk.
See references
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|